The nation of Zimbabwe has declined a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over Washington's demand for confidential data.
The decision became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative has since clarified that the US was requesting health data for research and commercial gain while refused to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged more dialogue to reach a deal agreeable to both sides so the country's critical HIV programme can proceed.
Broader Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court halted a similar deal with the US after legal challenges were filed about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and accountability.
According to statements, 16 African countries have to date signed these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our people if a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending systems previously established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how subsequent co-operation could be arranged in a way that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks should continue given that much of the nation's HIV programmes relied on external financing.
"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group added.
The halted deal underscores the ongoing challenges between receiving much-needed foreign assistance and protecting local interests in an ever more data-driven world.